human ck18 elisa kit  (Elabscience Biotechnology)

Journal: Journal of Endocrinological Investigation

Article Title: Quantitative ultrasound techniques and biochemical markers to assess liver steatosis and fibrosis in newly diagnosed acromegaly

doi: 10.1007/s40618-024-02384-5

Figure Lengend Snippet: The results of serum CK18, IGFBP7 and liver quantitative ultrasound

Article Snippet: Elabscience Human CK18 ELISA kit (detection range 6.25–400 mIU/mL, sensitivity < 3.75 mIU/ml, coefficient of variation (CV) < 10%) and Elabscience Human IGFBP7 ELISA (detection range 0.94–60 ng/ml, sensitivity < 0.56 ng/ml, CV < 10%) were used.

Techniques:

Journal: Journal of Endocrinological Investigation

Article Title: Quantitative ultrasound techniques and biochemical markers to assess liver steatosis and fibrosis in newly diagnosed acromegaly

doi: 10.1007/s40618-024-02384-5

Figure Lengend Snippet: Stepwise multivariate linear regression analysis for risk factors of increased liver stiffness

Article Snippet: Elabscience Human CK18 ELISA kit (detection range 6.25–400 mIU/mL, sensitivity < 3.75 mIU/ml, coefficient of variation (CV) < 10%) and Elabscience Human IGFBP7 ELISA (detection range 0.94–60 ng/ml, sensitivity < 0.56 ng/ml, CV < 10%) were used.

Techniques:

Journal: Journal of Endocrinological Investigation

Article Title: Quantitative ultrasound techniques and biochemical markers to assess liver steatosis and fibrosis in newly diagnosed acromegaly

doi: 10.1007/s40618-024-02384-5

Figure Lengend Snippet: Clinical, laboratory and ultrasonographic characteristics of the individuals

Article Snippet: Elabscience Human CK18 ELISA kit (detection range 6.25–400 mIU/mL, sensitivity < 3.75 mIU/ml, coefficient of variation (CV) < 10%) and Elabscience Human IGFBP7 ELISA (detection range 0.94–60 ng/ml, sensitivity < 0.56 ng/ml, CV < 10%) were used.

Techniques: Control, Fat

Journal: Journal of Endocrinological Investigation

Article Title: Quantitative ultrasound techniques and biochemical markers to assess liver steatosis and fibrosis in newly diagnosed acromegaly

doi: 10.1007/s40618-024-02384-5

Figure Lengend Snippet: Correlation analysis between quantitative ultrasound parameters, serum biomarkers and clinical parameters

Article Snippet: Elabscience Human CK18 ELISA kit (detection range 6.25–400 mIU/mL, sensitivity < 3.75 mIU/ml, coefficient of variation (CV) < 10%) and Elabscience Human IGFBP7 ELISA (detection range 0.94–60 ng/ml, sensitivity < 0.56 ng/ml, CV < 10%) were used.

Techniques: Fat

Journal: Aging (Albany NY)

Article Title: Coupling of serum CK20 and hyper-methylated CLIP4 as promising biomarker for colorectal cancer diagnosis: from bioinformatics screening to clinical validation

doi: 10.18632/aging.203804

Figure Lengend Snippet: The serum levels of CEA, CK18, CK20, CK8, MUC13 and EPCAM in CRC, CA patients and healthy controls. ( A ) Screening specific genes that encode secretory proteins in CRC by bioinformatics. ( B ) Testing the expression of candidate serum biomarker genes by Q-PCR in 8 cell lines. ( C ) Detection of the serum levels of CEA, CK18, CK20, CK8, MUC13 and EPCAM in CRC, CA patients and healthy controls by ELISA.

Article Snippet: Commercial ELISA kits were used to measure CEA, CK18, CK20, MUC13, CK8 and EPCAM (CUSABIO, China).

Techniques: Expressing, Biomarker Discovery, Enzyme-linked Immunosorbent Assay

Journal: Aging (Albany NY)

Article Title: Coupling of serum CK20 and hyper-methylated CLIP4 as promising biomarker for colorectal cancer diagnosis: from bioinformatics screening to clinical validation

doi: 10.18632/aging.203804

Figure Lengend Snippet: The expression of CEA, CK18 and CK20 in tumor tissues and cancer cell lines. The mRNA expression of CEA ( A ), CK18 ( B ) and CK20 ( C ) in certain tumor tissues and CRC tissues was analyzed by GEPIA. The protein expression of CEA ( A ), CK18 ( B ) and CK20 ( C ) in CRC tissues was stained by immunohistochemistry (IHC) and analyzed by HPA. The mRNA expression of CEA ( A ), CK18 ( B ) and CK20 ( C ) in cancer cell lines was analyzed by CCLE. Abbreviations: COAD: colon adenocarcinoma; READ: rectum adenocarcinoma.

Article Snippet: Commercial ELISA kits were used to measure CEA, CK18, CK20, MUC13, CK8 and EPCAM (CUSABIO, China).

Techniques: Expressing, Staining, Immunohistochemistry

Journal: Aging (Albany NY)

Article Title: Coupling of serum CK20 and hyper-methylated CLIP4 as promising biomarker for colorectal cancer diagnosis: from bioinformatics screening to clinical validation

doi: 10.18632/aging.203804

Figure Lengend Snippet: Correlation of serum biomarkers level or methylation status with clinicopathological characteristics.

Article Snippet: Commercial ELISA kits were used to measure CEA, CK18, CK20, MUC13, CK8 and EPCAM (CUSABIO, China).

Techniques: Methylation, Biomarker Discovery

Journal: Aging (Albany NY)

Article Title: Coupling of serum CK20 and hyper-methylated CLIP4 as promising biomarker for colorectal cancer diagnosis: from bioinformatics screening to clinical validation

doi: 10.18632/aging.203804

Figure Lengend Snippet: Evaluation of serum biomarkers level or methylation status in detection of CRC.

Article Snippet: Commercial ELISA kits were used to measure CEA, CK18, CK20, MUC13, CK8 and EPCAM (CUSABIO, China).

Techniques: Methylation, Biomarker Discovery

Journal: Contemporary clinical trials

Article Title: Methods to Improve the Noninvasive Diagnosis and Assessment of Disease Severity in Children with Suspected Nonalcoholic Fatty Liver Disease (NAFLD): Study Design

doi: 10.1016/j.cct.2018.10.012

Figure Lengend Snippet: Biomarkers Measured Biomarkers measured in this study. CK 18 = cytokeratin 18; CK 18 frag = CK18 fragments; CRP = c-reactive protein; ELISA = enzyme-linked immunosorbent assay; FGF-21 = Fibroblast growth factor 21; HA = Hyaluronic acid; IL-6 = interleukin 6; PAI-1 = plasminogen activator inhibitor-1; PIIINP = Amino-terminal propeptide of type III collagen; RBP-4 = retinol binding protein-4; RIA = Radioimmunoassay ; sRAGE = soluble receptor for advanced glycation end products; TIMP-1 = Tissue inhibitor of metalloproteinase 1; TNF- α = Tumor necrosis factor-α; YKL-40 = human cartilage glycoprotein-3

Article Snippet: Biomarker panels or biomarker algorithms previously identified in adult populations will also be calculated utilizing appropriate pediatric data (see ) and validated where appropriate. table ft1 table-wrap mode="anchored" t5 Table 1: caption a7 Test Method Assay Manufacturer/Catalogue # HA ELISA R & D Systems / DHYAL0 PIIINP ELISA Cloud Clone / SEA573Hu TIMP-1 ELISA R & D Systems / DTM100 YKL-40 ELISA Quidel / 8020 CK18 ELISA Diapharma / P10011 CK18 fragments ELISA Diapharma / {"type":"entrez-protein","attrs":{"text":"P10020","term_id":"135957","term_text":"P10020"}} P10020 A2-Macroglobulin ELISA Abcam / ab10888 Adiponectin RIA EMD Millipore / HADP-61HK Leptin ELISA Mercodia / 10–1199-01 sRAGE ELISA R & D Systems / DRG00 FGF-21 ELISA R & D Systems / DF2100 RBP-4 ELISA R & D Systems / DRB400 PAI-1 ELISA BioMedica Diagnostics / 822 TNF-α ELISA Alpco / 45-TNFHU-E01 IL-6 ELISA R & D Systems / Q6000B High Sensitivity CRP UV/VIS Beckman Coulter / OSR6199 Open in a separate window caption a8 Biomarkers Measured Biomarkers measured in this study.

Techniques: Enzyme-linked Immunosorbent Assay, Binding Assay, RIA Assay